Innovation & Products

The Regulatory Affairs Department of ELPEN is a strategic pillar for ensuring the full compliance of pharmaceutical products with the applicable regulatory framework, supporting the development, approval and lifecycle management across international markets.

D Ready® is a NON-PRESCRIPTION MEDICINE for regulating vitamin D blood levels. The active substance of D Ready® is Calcifediol. It is available in packs of 12 soft capsules, and each soft capsule contains 75 micrograms of calcifediol monohydrate.¹

Gopain, Double Action in Common Pain

The Elpenhaler® Inhaler is a proprietary, internationally patented, dry powder inhaler of ELPEN used for the administration of multiple single doses of medicines for respiratory diseases.

Pharmacovigilance is the science and the set of processes that contribute to the continuous monitoring of the safety of medicinal products, with the aim of protecting public health and maintaining a positive benefit-risk balance throughout their lifecycle.

Our strong drive to excel in research and development as well as make a crucial contribution to the education and smooth integration of young scientists led us to create the most significant - and the only privately owned - Experimental and Applied Biomedical Research laboratory in Greece.

Research and development of pharmaceutical products is a key strategic objective for ELPEN.